Citizens Business Bank lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,408 shares of the healthcare conglomerate’s stock after selling 171 shares during the period. Citizens Business Bank’s holdings in UnitedHealth Group were worth $4,916,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the 3rd quarter worth $27,000. Macroview Investment Management LLC increased its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the period. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Signature Resources Capital Management LLC increased its stake in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Finally, West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities research analysts have weighed in on the stock. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $626.84.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $565.39 on Wednesday. The business has a 50-day simple moving average of $586.36 and a two-hundred day simple moving average of $559.39. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a market cap of $520.31 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is Put Option Volume?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
- Basic Materials Stocks Investing
- Why Betting on Oil Over Gold Could Pay Off Big in 2025
- How to Calculate Options Profits
- Why MongoDB’s Drop Could Be Your Best Buy Opportunity for 2025
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.